Lauren Cooper Hand, MD
Gynecological Oncology · Jacksonville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 13 years
- University of Florida College of Medicine, 2013
Offices
1 location · Baptist MD Anderson Cancer Physicians Inc · 115 clinicians in this group
Hospitals listed: Baptist Medical Center - Beaches · Baptist Medical Center Jacksonville · Baptist Medical Center - Nassau. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Hand’s office at (904) 202-7300 to ask if they take your plan before you enroll.
State licence records
1 licence
- Florida ME145601Medical Doctor · since 2020 · expires 2028-01-31ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
3 placements
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Education
- University of Florida2009–2013
Residency and fellowship
- UPMC Medical Education Program, OBSTETRICS AND GYNECOLOGYPittsburgh, PA · 2017–2020
- Sidney Kimmel Medical College at Thomas Jefferson University, OBSTETRICS AND GYNECOLOGYPhiladelphia, PA · 2014–2017
- Sidney Kimmel Medical College at Thomas Jefferson University, OBSTETRICS AND GYNECOLOGYPhiladelphia, PA · 2013–2014
What else the board holds
Also licensed in
States the clinician told their board they are also licensed in. Only the states we check are verified.
Pennsylvania
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Baptist Health Medical Center - JacksonvilleJacksonville, FLAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Baptist Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Postoperative respiratory failure rate: 14.18 (10.48 to 17.88) · 2,854 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.183, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.374, Oct 2024 – Sep 2025
- Baptist Medical Center BeachesJacksonville Beach, FLAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Baptist Health, which runs 3 hospitalsPatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.04, Oct 2024 – Sep 2025
- Baptist Medical Center - NassauFernandina Beach, FLAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Baptist Health, which runs 3 hospitalsPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Baptist Health Medical Center - Jacksonville
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 1 worse of 8 measures. Readmissions: 2 better, 7 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative respiratory failure rateComplications and deaths | 14.18 (10.48 to 17.88) · 2,854 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.183 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.374 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.56 (0 to 1.27) · 5,191 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.17 (0.98 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 165.29 (132.38 to 198.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.5 · 378 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.3 · 615 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 1,390 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.3 · 1,627 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.2 · 1,437 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 12,137 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0.01 to 0.3) · 24,698 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.07 to 0.37) · 25,402 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.41 (3.08 to 5.73) · 6,567 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.49 (1.27 to 3.72) · 2,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.88 (0.88 to 2.87) · 6,107 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.66 (3.27 to 8.05) · 2,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.26 to 2.92) · 1,490 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.62 (0.25 to 0.99) · 20,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 137 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.568 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.923 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.19 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.838 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.4 · 1,002 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 2,103 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 15.1 · 721 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -11.2 · 1,639 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 9.6 · 1,755 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 2,215 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.5 to 7.2) · 914 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.8 (10.1 to 13.9) · 914 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 129 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.1 · 620 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.5 to 17.1) · 1,577 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1) · 3,311 cases | No different | Jan 2024 – Dec 2024 |
What patients said (680 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 59% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Baptist Medical Center Beaches
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 7 the same, 0 worse of 8 measures. Readmissions: 1 better, 5 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.04 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.38 (0.38 to 2.38) · 832 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.06 (0.68 to 1.44) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 168.32 (106.85 to 229.78) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 150 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 340 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 425 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 15 · 127 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,266 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 4,850 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 4,759 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.24 (1.01 to 5.48) · 856 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0 to 3.24) · 254 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.57 (0.96 to 4.17) · 803 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 14.93 (6.38 to 23.49) · 282 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.13 (2.11 to 10.16) · 252 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.16) · 199 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.24 (0 to 1.06) · 3,880 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 53 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.523 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.22 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 61 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 415 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -21.3 · 54 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -28.1 · 386 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 11 · 453 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15 · 549 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 51 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 196 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.6 to 15.9) · 1,167 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 774 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 80% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 63% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Baptist Medical Center - Nassau
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 2 the same, 0 worse of 3 measures. Readmissions: 1 better, 5 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.94 (0 to 1.98) · 396 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.63 to 1.51) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 10 · 80 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.1 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.1 · 198 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 292 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.4 · 75 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 1,096 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,431 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.5) · 2,376 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.44 (1.96 to 6.91) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 55 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.17 (0.5 to 3.85) · 271 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.3 (0 to 17.88) · 68 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.89 (1.65 to 10.13) · 53 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.15) · 144 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.79 (0 to 1.81) · 1,724 cases | No different | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 0.784 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.9 · 221 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.3 · 208 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -2 · 309 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 132 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.7 to 15.5) · 2,508 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 375 cases | No different | Jan 2024 – Dec 2024 |
What patients said (420 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 79% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 60% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 39% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$81,613
Medicare paid this office $81,613 for 152 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 49 | $12,577 | $103 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 11 | $8,683 | $789 |
| New patient visit (45+ min) | 44 | $5,934 | $135 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $5,207 | $96 |
| Short return visit (20+ min) | 57 | $4,927 | $65 |
See all 9 services
| Return visit (30+ min) | 49 | $12,577 | $103 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 11 | $8,683 | $789 |
| New patient visit (45+ min) | 44 | $5,934 | $135 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $5,207 | $96 |
| Short return visit (20+ min) | 57 | $4,927 | $65 |
| Long return visit (40+ min) | 27 | $4,489 | $150 |
| New patient visit (60+ min) | 24 | $4,073 | $170 |
| Exam of external female genitals using an endoscope | 18 | $2,182 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,039 | $146 |
Procedures Medicare counted
| Removal of the uterus | 14 | More than 88% of doctors who do this |
Procedures year by year
| Procedure | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | – | 13 | – | 12 | 11 |
| Exam of external female genitals using an endoscope | – | – | – | – | 24 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
152 Original Medicare patients in 2024. Average age 73 · Women 100% · Also on Medicaid 9% · Health risk score 1.66. Above the middle of the specialty; the typical gynecological oncology clinician is at 1.53.
Conditions among them: High blood pressure 75% · Cancer 56% · Coronary heart disease 38% · Diabetes 32% · Depression 27% · Chronic kidney disease 23% · COPD 18% · Heart failure 16% · Atrial fibrillation 15% · Stroke 13%.
The office billed $268,507, Medicare allowed $103,751 and paid $81,613; for 505 services of 47 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 152 | 505 | 73 | 1.66 | $268,507 | $81,613 |
| 2023 | 115 | 376 | 72 | 1.71 | $218,686 | $52,453 |
| 2022 | 97 | 365 | 72 | 1.53 | $218,757 | $52,220 |
| 2021 | 79 | 251 | 72 | 1.38 | $206,870 | $48,102 |
| 2020 | 17 | 36 | 72 | 0.91 | $23,049 | $5,377 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 12 | $8,952 | $746 |
| Return visit (30+ min) | 48 | $7,552 | $77 |
| New patient visit (45+ min) | 36 | $3,745 | $104 |
| Short return visit (20+ min) | 35 | $2,707 | $51 |
| Long return visit (40+ min) | 18 | $2,285 | $109 |
| New patient visit (60+ min) | 14 | $1,954 | $140 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $1,755 | $125 |
2022: 7 services
| Return visit (30+ min) | 45 | $8,829 | $74 |
| New patient visit (60+ min) | 24 | $3,438 | $143 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,282 | $152 |
| Short return visit (20+ min) | 26 | $2,279 | $48 |
| Long return visit (40+ min) | 15 | $1,882 | $118 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,569 | $56 |
| New patient visit (45+ min) | 14 | $1,477 | $106 |
2021: 6 services
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 13 | $8,688 | $668 |
| Return visit (30+ min) | 27 | $5,084 | $79 |
| New patient visit (60+ min) | 26 | $3,838 | $148 |
| New patient visit (45+ min) | 24 | $2,550 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,466 | $56 |
| Short return visit (20+ min) | 12 | $766 | $55 |
Drugs they prescribed that Part D paid
$308,596
Pharmacies billed $308,596 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 6% of their Part D prescriptions (15 of 251) in 2024. At or below the middle of the specialty; the typical gynecological oncology clinician is at 13%.
227 generic and 24 brand-name prescriptions · $308,596 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lynparza | 15 | $248,756 | $16,584 |
| Prochlorperazine Maleate | 33 | $530 | $16 |
| Gabapentin | 33 | $407 | $12 |
| Letrozole | 13 | $362 | $28 |
| Ondansetron | 30 | $238 | $8 |
See all 7 drugs
| Lynparza | 15 | $248,756 | $16,584 |
| Prochlorperazine Maleate | 33 | $530 | $16 |
| Gabapentin | 33 | $407 | $12 |
| Letrozole | 13 | $362 | $28 |
| Ondansetron | 30 | $238 | $8 |
| Lidocaine-Prilocaine | 15 | $164 | $11 |
| Duloxetine | 14 | $151 | $11 |
Year by year
| 2024 | 251 | 60 | 6% (15) | 10% | $308,596 |
| 2023 | 177 | 42 | 11% (20) | 11% | $208,040 |
| 2022 | 137 | 37 | 13% (18) | 8% | $128,174 |
| 2021 | 158 | 36 | 15% (23) | 10% | $171,723 |
| 2020 | 56 | 17 | None | None | $3,407 |
| 2019 | 38 | 21 | None | None | $4,878 |
| 2018 | 27 | 17 | None | None | $1,142 |
| 2017 | 11 | None | 0% (0) | 0% | $609 |
| 2016 | 13 | None | 0% (0) | 0% | $210 |
| 2015 | 20 | 13 | None | None | $1,302 |
| 2014 | 31 | 15 | None | None | $1,573 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Lynparza | 12 | $201,320 | $16,777 |
| Gabapentin | 28 | $484 | $17 |
| Prochlorperazine Maleate | 26 | $465 | $18 |
| Lidocaine-Prilocaine | 16 | $194 | $12 |
| Ondansetron | 20 | $139 | $7 |
2022: 4 drugs
| Ondansetron | 18 | $571 | $32 |
| Prochlorperazine Maleate | 22 | $422 | $19 |
| Gabapentin | 17 | $311 | $18 |
| Oxycodone | 15 | $161 | $11 |
2021: 4 drugs
| Lynparza | 11 | $167,842 | $15,258 |
| Prochlorperazine Maleate | 25 | $670 | $27 |
| Gabapentin | 17 | $270 | $16 |
| Ondansetron | 20 | $257 | $13 |
Money from drug and device companies
$122 in 2025
| 2025 | 2 | 2 | None | $122 |
| 2020 | 1 | 1 | None | $18 |
| 2019 | 1 | 1 | None | $132 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Daiichi Sankyo | Enhertu | $107 | 1 payment
|
| Innovation Technologies | Irrisept | $15 | 1 payment
|
See all 2 published payments
| Daiichi Sankyo | Meals · 2025-07-31 | Enhertu | $107 |
| Innovation Technologies | Meals · 2025-03-05 | Irrisept | $15 |
See earlier years (2020, 2019)
2020: $18
| Galen US | Synera | $18 | 1 payment
|
2019: $132
| AstraZeneca Pharmaceuticals LP | None | $132 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| ABBVIE INC. · Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab As Maintenance in Platinum-Sensitive Ovarian, Fallopian Tube, Or Peritoneal Cancer (Gloriosa) · 2025 | Their institution | $119,120 |
| Merck Sharp & Dohme LLC · Phase 2 Randomized Open-Label Multicenter Study of Combination of Onc-392 and Pembrolizumab for the Treatment of Patients With Platinum Resistant Ovarian Cancer Proc · 2024 | Their institution | $118,200 |
| Merck Sharp & Dohme LLC · Phase 2 Randomized Open-Label Multicenter Study of Combination of Onc-392 and Pembrolizumab for the Treatment of Patients With Platinum Resistant Ovarian Cancer Proc · 2023 | Their institution | $70,000 |
| ImmunoGen, Inc. · Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab As Maintenance in Platinum-Sensitive Epithelial Ovarian, Fallopian Tube, Or Peritoneal Cancer (Gloriosa) · 2023 | Their institution | $35,743 |
| ABBVIE INC. · Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab As Maintenance in Platinum-Sensitive Epithelial Ovarian, Fallopian Tube, Or Peritoneal Cancer (Gloriosa) · 2024 | Their institution | $12,857 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1164866778
- Licence
- FL ME145601Florida ME145601: Active
- Trained
- University of Florida College of Medicine, 2013 · 13 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207VX0201X (207VX0201X); Federal specialty code 207V00000X (207V00000X); Federal specialty code 207VG0400X (207VG0400X)
- Mailing address
- Po Box 746654, Atlanta, GA, 30374
- NPI first listed
- 2013-04-25
- NPI last updated
- 2025-04-30
- NPI record certified
- 2025-04-30
This is when the NPI record was last certified, not a medical board exam.